Cargando…
Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study
BACKGROUND: Recent studies demonstrated that failure of achieving pharmacodynamic targets of commonly used antibiotics is common in critically ill patients. Therapeutic drug monitoring (TDM) can contribute to optimize the exposure of beta-lactams and ciprofloxacin. While evidence for TDM of these an...
Autores principales: | Ewoldt, Tim M. J., Abdulla, Alan, van den Broek, Puck, Hunfeld, Nicole, Bahmany, Soma, Muller, Anouk E., Gommers, Diederik, Polinder, Suzanne, Endeman, Henrik, Spronk, Inge, Koch, Birgit C. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277596/ https://www.ncbi.nlm.nih.gov/pubmed/35831793 http://dx.doi.org/10.1186/s12879-022-07587-w |
Ejemplares similares
-
Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)
por: Abdulla, Alan, et al.
Publicado: (2020) -
Health Care Costs of Target Attainment for Beta-Lactam Antibiotics in Critically Ill Patients: A Retrospective Analysis of the EXPAT Study
por: Ewoldt, Tim M. J., et al.
Publicado: (2022) -
Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage Conditions
por: Bahmany, Soma, et al.
Publicado: (2023) -
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial
por: Ewoldt, Tim M. J., et al.
Publicado: (2022) -
Plasma protein binding of ceftriaxone in critically ill patients: can we predict unbound fractions?
por: Ewoldt, Tim M J, et al.
Publicado: (2023)